We are live on ! Find out more
APTO

Aptose Biosciences, Inc.

Delisted

APTO was delisted on the 1st of April, 2025.

Fund managers haven’t disclosed any holdings of APTO yet.

APTO Hedge Fund Activity: Q1 2026 in Review

4 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Aptose Biosciences, Inc. (APTO) for Q1 2026, worth a combined $40K — up 12% from $35.8K a quarter earlier.

Fund positioning in APTO was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 4 institutional investors held Aptose Biosciences, Inc. (APTO) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $40K of Aptose Biosciences, Inc. stock for Q1 2026, up 12% quarter-over-quarter.
  • 0 funds opened new Aptose Biosciences, Inc. positions in Q1 2026 and 0 closed out.

Based on aggregated 13F filings for Q1 2026.